176 related articles for article (PubMed ID: 12427966)
21. Could honey have a place in colitis therapy? Effects of honey, prednisolone, and disulfiram on inflammation, nitric oxide, and free radical formation.
Bilsel Y; Bugra D; Yamaner S; Bulut T; Cevikbas U; Turkoglu U
Dig Surg; 2002; 19(4):306-11; discussion 311-2. PubMed ID: 12207075
[TBL] [Abstract][Full Text] [Related]
22. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance.
Neurath MF; Fuss I; Kelsall BL; Presky DH; Waegell W; Strober W
J Exp Med; 1996 Jun; 183(6):2605-16. PubMed ID: 8676081
[TBL] [Abstract][Full Text] [Related]
23. An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis.
Nakase H; Okazaki K; Tabata Y; Uose S; Ohana M; Uchida K; Nishi T; Debreceni A; Itoh T; Kawanami C; Iwano M; Ikada Y; Chiba T
J Pharmacol Exp Ther; 2001 Jun; 297(3):1122-8. PubMed ID: 11356937
[TBL] [Abstract][Full Text] [Related]
24. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice.
Sugimoto K; Hanai H; Tozawa K; Aoshi T; Uchijima M; Nagata T; Koide Y
Gastroenterology; 2002 Dec; 123(6):1912-22. PubMed ID: 12454848
[TBL] [Abstract][Full Text] [Related]
25. Amelioration of trinitrobenzene sulfonic acid-induced colitis in mice by liquiritigenin.
Min JK; Lee CH; Jang SE; Park JW; Lim SJ; Kim DH; Bae H; Kim HJ; Cha JM
J Gastroenterol Hepatol; 2015 May; 30(5):858-65. PubMed ID: 25311527
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice.
Gurtner GJ; Newberry RD; Schloemann SR; McDonald KG; Stenson WF
Gastroenterology; 2003 Dec; 125(6):1762-73. PubMed ID: 14724829
[TBL] [Abstract][Full Text] [Related]
27. Tanshinone IIA ameliorates trinitrobenzene sulfonic acid (TNBS)-induced murine colitis.
Bai A; Lu N; Guo Y; Fan X
Dig Dis Sci; 2008 Feb; 53(2):421-8. PubMed ID: 17562175
[TBL] [Abstract][Full Text] [Related]
28. Assessment of anticolitic drugs in the trinitrobenzene sulfonic acid (TNBS) rat model of inflammatory bowel disease.
Whittle BJ; Cavicchi M; Lamarque D
Methods Mol Biol; 2003; 225():209-22. PubMed ID: 12769490
[No Abstract] [Full Text] [Related]
29. Arsenic trioxide reduces 2,4,6-trinitrobenzene sulfonic acid-induced murine colitis via nuclear factor-κB down-regulation and caspase-3 activation.
Singer M; Trugnan G; Chelbi-Alix MK
Innate Immun; 2011 Aug; 17(4):365-74. PubMed ID: 20693187
[TBL] [Abstract][Full Text] [Related]
30. Antibodies to interleukin 12 abrogate established experimental colitis in mice.
Neurath MF; Fuss I; Kelsall BL; Stüber E; Strober W
J Exp Med; 1995 Nov; 182(5):1281-90. PubMed ID: 7595199
[TBL] [Abstract][Full Text] [Related]
31. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
32. Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-κB and MAPK activation and restoring Th17/Treg cell balance.
Lim SM; Jeong JJ; Kang GD; Kim KA; Choi HS; Kim DH
Int Immunopharmacol; 2015 Apr; 25(2):493-503. PubMed ID: 25698557
[TBL] [Abstract][Full Text] [Related]
33. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
[TBL] [Abstract][Full Text] [Related]
34. VBP15, a novel dissociative steroid compound, reduces NFκB-induced expression of inflammatory cytokines in vitro and symptoms of murine trinitrobenzene sulfonic acid-induced colitis.
Damsker JM; Conklin LS; Sadri S; Dillingham BC; Panchapakesan K; Heier CR; McCall JM; Sandler AD
Inflamm Res; 2016 Sep; 65(9):737-43. PubMed ID: 27261270
[TBL] [Abstract][Full Text] [Related]
35. Prevention of trinitrobenzene sulfonic acid-induced experimental colitis by oral administration of a poly(lactic-coglycolic acid) microsphere containing prostaglandin E₂ receptor subtype 4 agonist.
Okamoto T; Uemoto S; Tabata Y
J Pharmacol Exp Ther; 2012 May; 341(2):340-9. PubMed ID: 22300734
[TBL] [Abstract][Full Text] [Related]
36. Tangeretin Inhibits IL-12 Expression and NF-κB Activation in Dendritic Cells and Attenuates Colitis in Mice.
Eun SH; Woo JT; Kim DH
Planta Med; 2017 Apr; 83(6):527-533. PubMed ID: 27806407
[TBL] [Abstract][Full Text] [Related]
37. A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction.
Fiorucci S; Wallace JL; Mencarelli A; Distrutti E; Rizzo G; Farneti S; Morelli A; Tseng JL; Suramanyam B; Guilford WJ; Parkinson JF
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15736-41. PubMed ID: 15505205
[TBL] [Abstract][Full Text] [Related]
38. RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease.
Bourreille A; Doubremelle M; de la Blétière DR; Segain JP; Toquet C; Buelow R; Galmiche JP
Scand J Gastroenterol; 2003 May; 38(5):526-32. PubMed ID: 12795464
[TBL] [Abstract][Full Text] [Related]
39. 15-deoxyspergualin prevents mucosal injury by inhibiting production of TNF-alpha and down-regulating expression of MD-1 in a murine model of TNBS-induced colitis.
Lee J; Kim MS; Kim EY; Park HJ; Chang CY; Jung DY; Kwon CH; Joh JW; Kim SJ
Int Immunopharmacol; 2007 Aug; 7(8):1003-12. PubMed ID: 17570317
[TBL] [Abstract][Full Text] [Related]
40. Vanillin improves and prevents trinitrobenzene sulfonic acid-induced colitis in mice.
Wu SL; Chen JC; Li CC; Lo HY; Ho TY; Hsiang CY
J Pharmacol Exp Ther; 2009 Aug; 330(2):370-6. PubMed ID: 19423842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
